BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25973277)

  • 1. SEMA6D Expression and Patient Survival in Breast Invasive Carcinoma.
    Chen D; Li Y; Wang L; Jiao K
    Int J Breast Cancer; 2015; 2015():539721. PubMed ID: 25973277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEMA6D Differentially Regulates Proliferation, Migration, and Invasion of Breast Cell Lines.
    Gunyuz ZE; Sahi-Ilhan E; Kucukkose C; Ipekgil D; Tok G; Mese G; Ozcivici E; Yalcin-Ozuysal O
    ACS Omega; 2022 May; 7(18):15769-15778. PubMed ID: 35571788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Semaphorin 6D and Snail are highly expressed in gastric cancer and positively correlated with malignant clinicopathological indexes].
    Qu S; Yang Z; Tao H; Ji F; Chen P; Liang J; Lu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Oct; 35(10):932-937. PubMed ID: 31814570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer.
    Baxter DE; Allinson LM; Al Amri WS; Poulter JA; Pramanik A; Thorne JL; Verghese ET; Hughes TA
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis.
    Lu Y; Xu Q; Chen L; Zuo Y; Liu S; Hu Y; Li X; Li Y; Zhao X
    Oncol Lett; 2016 Nov; 12(5):3967-3974. PubMed ID: 27895757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice.
    Sun Q; Peng Y; Zhao Q; Yan S; Liu S; Yang Q; Liu K; Rokosh DG; Jiao K
    Dev Biol; 2019 Aug; 452(1):1-7. PubMed ID: 31042497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinicopathological Significance and Correlative Signaling Pathways of an Autophagy-Related Gene, Ambra1, in Breast Cancer: a Study of 25 Microarray RNA-Seq Datasets and in-House Gene Silencing.
    He RQ; Xiong DD; Ma J; Hu XH; Chen G; Sun WL
    Cell Physiol Biochem; 2018; 51(3):1027-1040. PubMed ID: 30476925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PERK-Phosphorylated eIF2α Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer.
    Zou W; Bai Y; Wang X; Cheng K; Sun H; Zhang G; Wang X; Yang Z
    Cancer Biother Radiopharm; 2017 Oct; 32(8):282-287. PubMed ID: 29053414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
    Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
    Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.
    Morigi C
    Ecancermedicalscience; 2017; 11():732. PubMed ID: 28491135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers.
    Lefort S; Joffre C; Kieffer Y; Givel AM; Bourachot B; Zago G; Bieche I; Dubois T; Meseure D; Vincent-Salomon A; Camonis J; Mechta-Grigoriou F
    Autophagy; 2014; 10(12):2122-42. PubMed ID: 25427136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer.
    Fernandez-Jimenez N; Sklias A; Ecsedi S; Cahais V; Degli-Esposti D; Jay A; Ancey PB; Woo HD; Hernandez-Vargas H; Herceg Z
    Epigenetics; 2017; 12(11):964-972. PubMed ID: 29099283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
    Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
    Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway.
    Wang HB; Wei H; Wang JS; Li L; Chen AY; Li ZG
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):708-723. PubMed ID: 30611858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
    Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
    Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization.
    Kang S; Nakanishi Y; Kioi Y; Okuzaki D; Kimura T; Takamatsu H; Koyama S; Nojima S; Nishide M; Hayama Y; Kinehara Y; Kato Y; Nakatani T; Shimogori T; Takagi J; Toyofuku T; Kumanogoh A
    Nat Immunol; 2018 Jun; 19(6):561-570. PubMed ID: 29777213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer under age 40: a different approach.
    Ribnikar D; Ribeiro JM; Pinto D; Sousa B; Pinto AC; Gomes E; Moser EC; Cardoso MJ; Cardoso F
    Curr Treat Options Oncol; 2015 Apr; 16(4):16. PubMed ID: 25796377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide screen identifies a novel prognostic signature for breast cancer survival.
    Mao XY; Lee MJ; Zhu J; Zhu C; Law SM; Snijders AM
    Oncotarget; 2017 Feb; 8(8):14003-14016. PubMed ID: 28122328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
    Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
    Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulatory roles of lncRNAs in the process of breast cancer invasion and metastasis.
    Zhou S; He Y; Yang S; Hu J; Zhang Q; Chen W; Xu H; Zhang H; Zhong S; Zhao J; Tang J
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30217944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.